TP53 and neoplasm: As TP53 is most frequently affected by missense mutations that not only disrupt the wild-type p53 functions described above, but often simultaneously create neomorphic gain-of-function activities that operate in metastasis and therapy resistance, it is conceivable that mutant p53 proteins actively reprogram EV-based tumor cell communication.